Antibody to TNF receptor-like molecules
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 4, 2009
Grant Date -
Jan 18, 2007
app pub date -
May 17, 2006
filing date -
Sep 5, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully